Kathleen Laporte, Director at Q32 Bio, holds ― shares in Q32 Bio (Ticker: QTTB), holds 7.38K shares in Precipio (Ticker: PRPO), holds 971.83K shares in CERo Therapeutics Holdings (Ticker: CERO). Most recently, Kathleen Laporte ― shares of Q32 Bio on ― for an estimated value of ―.
Kathleen Laporte latest transaction was an Uninformative Buy of ―.
What was Kathleen Laporte's most profitable transaction?
Kathleen Laporte’s most profitable transaction was an Informative Sell of ETNB stock on July 18, 2023. The return on the trade was 52.80%.
What is Kathleen Laporte's role in Q32 Bio?
Kathleen Laporte's role in Q32 Bio is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.